Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER study

BACKGROUND: The multinational phase 3b DELIVER trial was designed to evaluate the efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures across 17 countries. In the placebo-controlled portion, eptinezumab relative to placebo demonstrated great...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbanti, Piero, Goadsby, Peter J., Lambru, Giorgio, Ettrup, Anders, Christoffersen, Cecilie Laurberg, Josiassen, Mette Krog, Phul, Ravinder, Sperling, Bjørn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716694/
https://www.ncbi.nlm.nih.gov/pubmed/36460983
http://dx.doi.org/10.1186/s10194-022-01521-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716694/
https://www.ncbi.nlm.nih.gov/pubmed/36460983
http://dx.doi.org/10.1186/s10194-022-01521-w

Ejemplares similares